Marker Therapeutics, Inc.MRKRNASDAQ
Loading
Cost of Revenue Over TimeContracting
Percentile Rank57
3Y CAGR-15.1%
5Y CAGR-17.3%
Year-over-Year Change
Direct costs attributable to producing goods sold
3Y CAGR
-15.1%/yr
vs -44.3%/yr prior
5Y CAGR
-17.3%/yr
Consistent
Acceleration
+29.1pp
Accelerating
Percentile
P57
Within normal range
vs 5Y Ago
0.4x
Contraction
Streak
1 yr
Consecutive declineContracting
| Period | Value | YoY Change |
|---|---|---|
| TTM | $7.31M | -45.7% |
| 2024 | $13.47M | +29.3% |
| 2023 | $10.42M | -13.0% |
| 2022 | $11.97M | +278.4% |
| 2021 | $3.16M | -83.2% |
| 2020 | $18.88M | +47.9% |
| 2019 | $12.76M | -89.7% |
| 2018 | $124.00M | +2261.4% |
| 2017 | $5.25M | - |
| 2016 | $0.00 | - |